

In the Top 10% of 2126 Similar Sized Companies on Comparably
In the Top 15% of 707 Nearby Companies in New York
1st place versus 3 competitors rated on Comparably
With over two decades in the healthcare industry, De Witte brings global public company leadership experience as well as deep technological, operational and commercial expertise to Integra. For the past five years, De Witte served as Chief Executive Officer of Barco N.V. (Euronext: BAR), where he created shareholder value through digital innovation and new product development, commercial acceleration, international market growth and operational excellence while effectively leading the company through the COVID-19 pandemic. In addition, De Witte spent 17 years in senior-level leadership roles at GE, including serving as President and CEO of GE Global Healthcare IT, where he had full global P&L responsibility for product management, technology and software development, commercialization, services and solutions delivery. Prior to GE, De Witte spent five years in strategic consulting at McKinsey and three years in operations at Procter & Gamble. De Witte currently serves on the Board of Directors of ResMed (NYSE: RMD, ASX: RMD), a global leader in digital health technologies and cloud-connected medical devices that transform care for people with sleep apnea, COPD and other chronic diseases.
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Integra LifeSciences.
Based on 180 ratings, Jan De Witte ranks right above EndoChoice's CEO, Mark Gilreath.
Integra LifeSciences' CEO is highly regarded by the Communications department, the IT department, and the Operations department. However, the Sales department, Male employees, and the Finance department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.
Integra LifeSciences ranks in the Top 10% of other companies on Comparably with 1,001-5,000 Employees for CEO Rating Score.
Integra LifeSciences ranks in the Top 15% of other companies in New York for CEO Rating Score.
